Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care
Within a university-based PC population, the proportion of patients newly prescribed an XOI receiving up-titration or achieving SU less than 6 mg/dL within 6 months of medication initiation is low, suggesting that a treat-to-target approach is underused.
Authors
- Joseph J. Saseen (ORCID: https://orcid.org/0000-0003-0341-5140)
- Liza W. Claus
- Sarah J. Billups (ORCID: https://orcid.org/0000-0003-3735-5262)
- Madison E. Auten
Institutions
- Saint Luke's Health System (US)
- New York Times (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-08-30
- DOI
- https://doi.org/10.18553/jmcp.2025.31.9.922
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00